POS1204 LOW POSITIVITY RATE IN ANTIBODY SARS-COV2 TESTS IN PATIENTS WITH RHEUMATIC DISEASES TREATED...
POS1204 LOW POSITIVITY RATE IN ANTIBODY SARS-COV2 TESTS IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH RITUXIMAB. A CASE CONTROL STUDY OF A HIGH IMPACT SARS-COV2 INFECTION AREA
About this item
Full title
Author / Creator
Publisher
Elsevier B.V
Journal title
Language
English
Formats
Publication information
Publisher
Elsevier B.V
More information
Scope and Contents
Contents
Diagnosis of previous SARS-COV2 infection may be challenging in immunocompromised patients.
To analyze positivity rate to SARS-COV2 antibody tests (SC2AT) in patients diagnosed of rheumatic diseases (RMD) treated with Rituximab.
We conducted a case-control study of patients diagnosed of RMD followed in a referral hospital in Madrid, Spain. Po...
Alternative Titles
Full title
POS1204 LOW POSITIVITY RATE IN ANTIBODY SARS-COV2 TESTS IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH RITUXIMAB. A CASE CONTROL STUDY OF A HIGH IMPACT SARS-COV2 INFECTION AREA
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1136_annrheumdis_2021_eular_2082
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1136_annrheumdis_2021_eular_2082
Other Identifiers
ISSN
0003-4967
DOI
10.1136/annrheumdis-2021-eular.2082
